Development of mycobacterial growth inhibition assays for the early evaluation and gating of novel TB vaccine candidates

<p>Tuberculosis poses a serious global health threat, with an estimated 9 million new cases and 1.5 million deaths annually. The current vaccine, BCG, is inadequate but development of an effective alternative is severely hampered by the lack of an immune correlate of protection. Candidate vacc...